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Apoptosis in the repair process of experimental proliferative
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Apoptosis in the repair process of experimental proliferative glomeru-
lonephritis. The recovery from the proliferative glomerulonephritis (GN)
with reduction of hypercellularity is known in various experimental and
human GN. To elucidate the participation of apoptosis in GN, we studied
the experimental Thy-1.1 GN for six weeks. Apoptosis was recognized by
both light and electron microscopy, and the biochemical expression of
apoptosis was morphologically confirmed by in Situ end-labeling method of
fragmented DNA, using terminal deoxy-transferase. Mesangioprolifera-
tive GN was induced by a single administration of anti-Thy-1.1 monoclo-
nal antibody in a rat. Mesangial cell proliferation started early in the
process and the number of glomerular cells peaked from day 7 to day 10.
Subsequently, the degree of proliferative lesion diminished with obvious
reconstruction of the capillary structure, as well as decrease in the number
of glomerular cells. During this period, proliferated mesangial cells
returned to their original level of cellularity and apoptosis apparently
increased in number among the glomeruli. Apoptosis was significantly
noted from day 7 to week 4 and was in its maximum at day 10 to week 2.
Following this period, by week 6 most of the glomeruli reverted to their
original structure. The number of infiltrated neutrophils and macrophages
in the glomeruli slowly decreased during the course of the disease, and a
few apoptosis were also observed. It is concluded that proliferated
glomerular cells regress by apoptosis in the repairing process of GN.
Apoptosis plays an essential role in the recovery to the original glomerular
structure in GN.
As an experimental model of proliferative glomerulonephritis
(GN) induced by an antibody to Thy-1.1, antigen is well estab-
lished and is characterized by acute mesangial proliferation,
hypercellularity and expansion of the mesangial matrix resembling
the morphological feature of human proliferative GN [1—41.
However, this induced disease is transient and glomeruli can
recover from the massive glomerular cell proliferation and me-
sangial matrix expansion [4—6]. The recovery from proliferative
GN is known in various human diseases, such as post-streptococ-
cal acute GN, Schönlein-Henoch purpura nephritis as well as
some proliferative GN under effective treatments [7—9]. However,
the repairing process from proliferative GN has not been thor-
oughly investigated to date. Therefore, little is known about the
repairing process of the GN and the mechanisms of the resolution
of glomerular disease, namely, their returning to normal from the
hyperplastic glomerulus.
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Recently, one manner of cell death defined as apoptosis has
been widely recognized [10—13], and the various roles of apoptosis
have been reported. One of the roles of apoptosis is as a regulated
mechanism for the deletion of "unwanted" cells, and apoptosis
plays an important role in maintaining homeostasis by regulating
cell numbers in tissues and organs [14—19]. More recently, some
reports indicate that apoptosis can occur in glomerular cells [20,
21], and glomerular infiltrated neutrophils can also undergo
apoptosis during GN [22]. However, the origin of apoptotic cells
and the role of apoptosis during GN is still not clear.
To elucidate the role of apoptosis during the process of GN, we
studied the experimental Thy-1.1 GN, especially focusing on the
correlation between recovery from proliferative GN and the
occurrence of apoptosis. Apoptosis was recognized morphologi-
cally, and nuclear DNA fragmentation of apoptosis was also
recognized on tissue sections using a specific labeling method of
DNA breaks with terminal deoxy-transferase (TdT).
Methods
Animals
Male Wistar rats (Saitama Experimental Animal Supply, Ja-
pan) weighing 180 to 200 g were used for this study. They were
anesthetized by ether and administered the anti-Thy-1.1 antibody
intravenously, followed by open renal biopsy and sacrifice.
Experimental design
In experimental groups, mesangial proliferative GN was in-
duced in rats with a single injection of anti-rat Thy-1.1 monoclonal
antibody (IgGi) (Cedarlane Laboratories, Ontario, Canada). An
intravenous dose of 0.25 p1 ascites/100 g body wt was used to
induce disease. The experimental animals were sacrificed, or open
renal biopsy was performed on days 1, 2, 4, 7, and 10, and 2, 3, 4
and 6 weeks after the administration of anti-Thy-1.1 antibody.
Each experimental group consisted of three or more kidneys. Six
normal aged-matched, unmanipulated Wistar rats were studied as
controls.
Histological examination
After removal of the kidney, tissue blocks for light microscopic
study were fixed in 4% buffered paraformaldehyde and embedded
in paraffin with usual manner. Periodic acid-Schiff (PAS), and
periodic acid-methenamine silver (PAM) stains were performed
for light microscopic studies. The naphthol AS-D chloroacetate
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Table 1. The number of PCNA + cells, neutrophils, macrophages, total cells, nuclear points, TdT + cells and apoptotic cells per glomerular
cross section
PCNA + cells Neutrophils Macrophages
Total cells
.Nuclear points
points
TdT + cells Apoptotic cells
cells cells
Control 0.5 0.1±0.0 0.4±0.1 70.5± 1.0 19.0±0.3 0.0±0.0 0.0±0.0
Day 1 2.2 Q3 3.6 0.4° ND 55.1 1.3° 14.2 0.3° 0.0 0.0 0.1 0.1
Day 2 8.3 0.5° 2.7 0.3° ND 53.7 i.la 14.1 0.3° 0.1 0.0 0.1 0.1
Day4 22.1 1.3° 1.6±0.3° 7.5±0.4° 71.6± 1.3 18.2±0.3 0.1 ±0.1
Day7 9.3±0.7° 0.2 3.7±0.3° 107.5 25.8 0.6±0.2a 0.6±0.la
DaylO 3.4±0.4 0.1±0.1 2.1±0.2° 104.2±1.5° 25.3±0.4° o.7±o.la o.7±o.la
Week2 0.7±0.2 0.2±0.1 1.9±0.2° 95.1±1,9° 24.3±0.5° o.7±o.ia 0.7±0.1°
Week3 0.6±0.2 0.1±0.1 0.9±0.2a 84.7± 1.2° 22.8±0.3a 0.3±0.1° 0.4±0.1°
Week4 0.5±0.3 0.1±0.0 0.6±0.2 78.4±1.2a 2L1±0.3° 0.2±0.P 0.2±0.1°
Week6 0.7±0.2 0.1±0.1 0.6±0.1 72.6± 1.1 19.4±0.3 0.1±0.1 0.1±0.1
Values are included increments of 0.05 cells and over as a unit and discounted the rest. Values are expressed as mean SEM.
ap < 0.05 when compared to control
esterase staining was performed by the modified Moloney's
method [23] to detect neutrophils.
For immunohistochemistry of ED-i, which is the detection of
macrophages [24, 25], freeze-dried tissue blocks were prepared.
Small samples of tissues were frozen in thy ice-acetone and dried
under —60°C in a vacuum chamber (TIS-U-DRYT° Freeze-
Dryers Model TFD-3, FTS SYSTEM) for five days. Then paraffin
was melted gradually by raising the chamber temperature up to
60°C and embedded. In immunohistochemical studies for the
detection of the proliferating cell nuclear antigen (PCNA) and
Thy-1.1 antigen, 4% paraformaldehyde-fixed paraffin-embedded
tissue blocks were used. The 2.5 m thick sections were prepared
from the freeze-dried or 4% paraformaldehyde-fixed blocks and
were treated with 0.3% hydrogen peroxide in methanol for 30
minutes, and then incubated for 60 minutes with one of the
primary antibodies, anti-ED-i monoclonal antibody (IgGI,
Chemicon, CA, USA), anti-PCNA monoclonal antibody (IgG2a,
Dakopatts, Denmark), or anti-Thy-1.1 polyclonal antibody [26].
Subsequently, the tissue sections were incubated with a biotiny-
lated rat anti-mouse IgGi antibody, a biotinylated rat anti-mouse
IgG2a antibody, or a biotinylated goat anti-rabbit antibody, at a
dilution of 1:200 in PBS for 60 minutes, and were treated with
avidin-biotin-peroxidase complex solution for 60 minutes. The
reaction products were visualized by using hydrogen peroxide,
containing 3,3'-diaminobendizine in 0.05 M Tris buffer, then
examined under a light microscope. Mouse IgGi bound to renal
tissues of rats injected with the monoclonal antibody to Thy-1.1
was also detected by an immunoperoxidase technique, using a
biotinylated rat anti-mouse IgGi antibody (dilution 1:200), and
were reacted with avidin-biotin-peroxidase complex.
For the electron microscopic study, the small blocks were fixed
in 2.5% glutaraldehyde solution in phosphate buffer (pH 7.4) and
postflxed with 1% osmium tetroxide, dehydrated, and embedded
in Epon 812. Ultrathin sections were stained with uranyl acetate
and lead citrate, then examined with a Hitachi H7100 electron
microscope.
Identification of fragmented DNA associated with apoptosis in
histological sections
The biochemical feature of apoptosis was characterized by
activation of endonuclease [27] which degraded genomic DNA at
internucleosomal linker regions, producing characteristic 180-185
base pairs fragments. These gave rise to a characteristic DNA
"ladder" pattern on gel electrophoresis of extracted DNA. In
histological sections, fragmented nuclear DNA associated with
apoptosis were labeled with biotinylated deoxyuridine, introduced
by terminal deoxy-transferase (TdT), using the Gavrieli's method
[28]. However, there is a possibility that this technique detected
DNA breaks from any cause including necrosis [29]. To elucidate
the correlation between TdT-mediated DNA nick end-labeled
(nick end-labeled) cells and apoptosis, the nick end-labeling
method and PAS stain were performed on serial sections. The
nick end-labeling method used TdT to label the 3'-OH ends of
fragmented DNA with biotinylated deoxyuridine. After the expo-
sure of nuclear DNA on histological sections by 20 j.tg/ml protein-
ase K (Promega, WI, USA), TdT (Life Technologies, MD, USA)
was used to incorporate biotinylated deoxyuridine (Boehringer
Mannheim GmbH, Germany) at sites of DNA breaks. The
biotinylated signal was amplified with avidin-peroxidase (Nichirei,
Tokyo, Japan), allowing for its identification by light microscopy.
To elucidate the correlation between apoptotic cells and mesang-
ial cells, the nick end-labeling method for apoptotic cells and
immunostaining for Thy-1.1 antigen (mesangial cell marker) were
performed on serial sections.
Quantification of histologic findings
In each kidney sample, more than 30 glomerular cross sections
were sequentially examined for the following variables: total
cellularity, the mean number of glomerular nuclei as well as the
mean number of nuclear points [30], which except for the
influence of nuclear hypertrophy, was per glomerular cross section
in PAS-stained tissue sections; proliferation, the mean number of
PCNA-positive cells per glomerular cross section; neutrophil
infiltration, the mean number of naphthol AS-D chioroacetate
esterase-positive cells per glomerular cross section; macrophage
infiltration, the mean number of ED 1-positive macrophages per
glomerular cross section; incidence of apoptotic cells, the mean
number of TdT-mediated DNA nick end-labeled cells (TdT +
cells) as well as the mean number of apoptotic cells in PAS-
stained sections per glomerular cross section. The glomerular
cross sections containing a minor portion of the glomerular tuft
were excluded from analysis. These results are expressed as the
mean standard error (sEM), and statistical analysis was per-
formed by Student's t-test.
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Fig. 1. Mo,phological changes of glomendus in the repairing process of Thy-1.1 GN. A. One week after disease induction hypercellularity and expansion
of the mesangial matrix are noted. Apoptotic cells and apoptotic bodies are found (4,) in proliferative regions. Inset. High magnification view of the
apoptotic cells. B. Two weeks after disease induction decreases of cell proliferation and matrix components are seen with reconstruction of capillary
structure. Apoptotic cells and bodies (4,). C. Three weeks after disease induction segmental proliferation remains, and hypercellularity is gradually
subsiding with increase of capillary lumen. Apoptotic cells and bodies ( 4,). Inset. High magnification view of one of the apoptotic bodies with a nuclear
fragment. D. Four weeks after disease induction most of the glomeruli revert to their original structure. Apoptotic cells and bodies (4, ). A—D; PAS stain,
x 750.
Results
Histological changes during Thy-i. 1 GN
Mesangial proliferative GN was induced in rats with one shot of
monoclonal antibody to the Thy-1.1 antigen present on mesangial
cells. Following injection of anti-Thy-1.1 antibody rats developed
mesangiolysis at day 1, and exhibited diminished glomerular
cellularity (Table 1) consistent with the loss of mesangial cells. At
this time, many naphthol AS-D chloroacetate esterase-positive
neutrophils infiltrated in the glomerulus (Table 1). The presence
of ED 1-positive macrophage was not conclusively confirmed from
day 1 to day 2, because mouse IgGi (administrated monoclonal
anti-Thy-1.1 antibody) was found in the glomeruli. Thereafter,
mouse IgGi could not be detected at day 4, and many ED1-
positive macrophages began to be detected in the glomeruli.
Although our results could not show the number of infiltrated
macrophages in the early phase, other studies on Thy-1.1 GN [31,
32] reveal that the number of influx of macrophages peaks at day
1 and thereafter decreases gradually. PCNA-positive proliferated
glomerular cells were already increasing above the normal range
at day 1 and increased further until day 4 (Table 1). With an active
proliferative response, the total cellularity increased to the level of
the control at day 4, and reached to the highest value at day 7 to
10 in mesangial proliferative GN (Fig. 1A). By immunohistochem-
istry, most of the proliferating cells were positive for Thy-1.1
antigen (Fig. 2A). The nuclei of the proliferating glomerular cells
were hypertrophic. For instance normal nuclei in glomeruli had
mean diameter of 6.8 0.3 m, while the nuclei at day 7 of
experimental group was 7.9 2.0 m. In accordance with
previous observations [4—6], Thy-1.1 GN was transient, and
massive mesangial cell proliferation and matrix expansion gradu-
ally subsided and the reconstruction of the capillary structure took
place. On week 2, the glomerular cell proliferation and matrix
components diminished with the reconstruction of the glomerular
vasculature (Fig. 1B). On weeks 3 to 4, although focal and
segmental remnant of proliferative changed, glomerular hypercel-
lularity gradually decreased and the capillary lumen increased
(Fig. 1 C, D). By week 6, most of the glomeruli reverted to their
original structure. During this period, the glomerular cellularity as
well as the number of Thy-1.1 positive cells slowly decreased to
the normal level (Fig. 2B, Table 1). Increased numbers of
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Fig. 2. Proliferative lesions and mesangial cells. A. One week after disease induction most of proliferating cells are expressing Thy-1.1 antigen. B. Six
weeks after disease induction most of glomeruli revert to their original structure, and proliferated Thy-1.1 positive mesangial cells also revert to their
original cellularity (immunohistochemistry for Thy-1.1 antigen, X 600).
glomerular influx of neutrophils and macrophages in early phase
of GN gradually decreased to normal level until day 7 and week 4,
respectively (Table 1).
Between day 7 and week 4, numerous apoptotic cells and
bodies, occasionally containing nuclear fragments and often sur-
rounded by clear vacuoles, were found in proliferative regions by
light microscopy (Fig. 1, Table 1). By electron microscopy, various
type of apoptotic cells and bodies were present in proliferated
mesangial areas. Scattered individual cells underwent early apop-
tosis, characterized by condensation of the nucleus and cytoplasm
in mesangial areas (Fig. 3A). Since the mesangial cells have
properties similar to those of smooth muscle cells, identification is
possible through confirmation of the presence of microfilaments
and attachment bodies within the cytoplasm [33]. Figure 3A shows
one apoptotic cell in the mesangial area; almost intact mesangial
cells with bundles of microfilament were connected by junctional
complexes, and this strongly suggested that this apoptotic cell was
of mesangial origin. Early apoptotic bodies containing nuclear
fragment with crescentic condensation of the chromatin were also
found in proliferated mesangial areas (Fig. 3B). The typical
apoptotic bodies with dense nuclear and cytoplasmic fragments
were found in phagocytic cells such as infiltrated macrophages or
mesangial cells in mesangial areas (Fig. 3C). Degraded apoptotic
bodies, which were formed by the action of lysosomal enzymes in
phagocytosing cells, were found within the surviving mesangial
cells (Fig. 3D).
Identification of fragmented DNA associated with apoptosis in
tissue sections
In addition to morphological features, the biochemical feature
of apoptosis were also confirmed by in situ nick end-labeling
method of fragmented DNA using TdT. This technique is not
specific for apoptosis because the DNA degradation also occurs
during necrosis. We carefully examined the characteristics of
TdT-mediated DNA nick end-labeled (nick end-labeled) cells,
comparing them to the neighboring PAS-stained section. Most of
the nick end-labeled cells in the glomeruli during the recovery
phase of Thy-1.1 GN were identified as apoptotic (Fig. 4), and no
necrosis was seen in the glomeruli. A few individual nick end-
labeled glomerular cells were quite similar in appearance to
normal-looking cells without condensation of nucleus and cyto-
plasm. We considered them to be possibly very early apoptotic
cells. Condensation of nucleus and cytoplasm were not discernible
by light microscopy, but DNA fragmentation had occurred and
the apoptotic process had begun. To elucidate the origin of
apoptotic cells, the nick end-labeling method and immunostaining
for Thy-1.1 antigen (mesangial cell marker) were performed on
serial sections. Typical apoptotic cells containing nuclear frag-
ment and surrounded by clear vacuole among proliferated me-
sangial cells were stained positively by the nick end-labeling
method (Fig. 5A). Moreover, individual nick end-labeled cells in
proliferative lesions were also expressing Thy-1.1 antigen (Fig.
5B). These data indicated that many apoptotic glomerular cells
were identified as having mesangial cell origin. A few apoptotic
cells were not stained by immunostaining for Thy-1.1 antigen (Fig.
5C), and this indicated that these cells in capillary aneurysm were
not of mesangial origin, but were considered to be infiltrated
mononuclear macrophages. A few infiltrated polymorphonuclear
leukocytes in glomeruli were stained positively by the nick end-
labeling method (Fig. 6C).
In the control kidneys, only a few nick end-labeled and apop-
totic cells in PAS-stained sections were identified in the glomer-
ulus (4 cells/200 glomerular cross sections). Numerous nick end-
labeled glomerular cells appeared in proliferative regions at day 7
(Fig. 6A), and increased further on day 10 to week 2 (Fig. 6B,
Table 1). Thereafter, the incidence of nick end-labeled cells
decreased gradually, but nick end-labeled cells were found in a
remnant segment of proliferative region (Fig, 6C), while no
differences of the incidence of nick end-labeled cells with the
controls were observed 6 weeks after disease induction (Fig. 6D,
Table 1). The incidence of apoptosis in PAS-stained sections was
also indicated for very similar frequencies of the incidence of nick
end-labeled cells (Table 1).
Discussion
The present study demonstrates the regression of hyperplastic
glomerular cellularity to the normal value, as well as the role of
apoptosis in recovery from experimental proliferative GN induced
with anti-Thy-1.1 antibody. Apoptosis is recognized morphologi-
cally, and nuclear DNA fragmentation associated with apoptosis is
also recognized by the in situ DNA nick end-labeling method on
tissue sections using TdT.
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Fig. 3. Various types of apoptotic cells and bodies on week 2. A. An individual mesangial cell undergoing early apoptosis in mesangial area (X 4,000).
B. An early apoptotic cell contains nucleus with crescent condensation of the chromatin (*) in the mesangial area (X 5,500). C. Two clusters of apoptotic
bodies (J.) contain a nuclear fragment (*) in phagocytic cells in mesangial area (X 3,500). D. A degraded apoptotic body contains a nuclear fragment
(*) in mesangial cell (x 2,500).
Fig. 4. TdT-mediated DNA nick end-labeled cells and apoptotic cells. Nick end-labeling method (A) and PAS stain (B) on serial sections on day 10. A.
Two nick end-labeled cells (.) are observed in proliferative region. B. Nick end-labeled cells in A are typical apoptotic bodies (, ) which surrounded
by clear vacuole. (x 800). C. Higher magnification view of the apoptotic bodies in B. One of apoptotic bodies contains a nuclear fragment (X 1,700).
Recovery from mesangial proliferative GN extracellular matrix continued, and resulted in glomerular sclero-
sis in the progressive stage [6, 34]. However, the recovery from
One of the key features of human GN is the proliferation of proliferative GN with a reduction of hypercellularity is also known
glomerular mesangial cells and glomerular hypercellularity. In in a number of human GN studies [7—9]. On the other hand,
chronic GN, prolonged mesangial cell proliferation with increased experimental proliferative GN is used as a model to elucidate the
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Fig. 5. Apoptotic cells and mesangial cells. TdT-
mediated DNA nick end-labeling method for
apoptotic cell (A, C and E) and Immuno-
histochemistry for Thy-1.1 antigen (B, D and F)
on serial sections. In both A and B, the (j,)
indicates the same cell at week 2. A typical
apoptotic cell contains nuclear fragments and
surrounded by clear zone in the group of the
mesangial cells, which are stained positively by
the nick end-labeling method (x 900). In both
C and D, the (,) indicates the same cell on
week 2. This nick end-labeled glomerular cell is
identified as mesangial cell with Thy 1.1
expression (X 700). In both E and F, the (1')
indicates the same cells on day 4. Two nick
end-labeled cells in capillary aneurysm are not
stained by immunostaining for Thy-1.1 antigen.
This indicates that these cells in capillary
aneurysm are not of mesangial origin, and are
infiltrated mononuclear macrophages (X 600).
pathobiochemical basis for GN in humans. Recently, experimen-
tal GN induced by injection of an antibody to the Thy-1.1 antigen,
which is present on the surface of the rat mesangial cell, is well
established [1—4]. A remarkable feature of this experimental GN
is the reversibility of its mesangial lesions; most of the glomeruli
reverted to nearly their original structure in around weeks 4 to 6
after the disease induction [4—61. During this period, total gb-
merular cellularity also reverted to its original cellularity [4, 6].
Our results also indicated that during the recoveiy from GN,
massive mesangial cell proliferation and matrix expansion gradu-
ally subsided with reconstruction of capillary structure, and with a
decrease in the number of glomerular cells, reached normal
cellularity at week 6.
Apoptosis and recovery process of GN
In recent years, apoptosis has been widely recognized as one
manner of the cell death which is morphologically and biochem-
ically different from the ordinary necrosis [10—13]. Recent studies
demonstrate that apoptotic cell death can occur in many types of
human proliferative GN, including IgA nephropathy, lupus ne-
phritis, systemic vasculitis and hemolytic uremic syndrome [20,
21]. It has been known that apoptosis occurs when death is a part
of organizing tissue reaction, such as in embryogenesis, in meta-
morphosis, in endocrine-dependent tissue atrophy, in the control
of normal tissue turnover, and in the wound healing [11—13]. More
recently, cell deletion by apoptosis has been described as a
regulation of cell numbers during pathologic tissue hyperplasia of
many organs and tissues [14—19]. During resolution and remod-
eling of the inflammatory response, cell deletion by apoptosis has
been also described as a regulation of cell numbers. Polunovsky et
al [35] described that in the deletion of hyperplastic fibroblasts
and endothelial cells is attributable to the cell death during lung
remodeling after injury. Our previous study of the repair process
of ischemic renal tubular necrosis demonstrated the initial excess
epithelial proliferative response after tubular necrosis, and that
hyperplastic epithelial cells regressed to the normal level mainly
by apoptosis [36]. There is evidence to suggest that excess
hyperplastic mesangial cells can undergo apoptosis during reso-
lution of the inflammatory response. Darby, Skalli and Gabbiani
[37] report that myofibroblasts can undergo apoptosis during
experimental wound healing. This suggests that stimulated myo-
fibroblast-like mesangial cells [3] may also be capable to under-
going apoptosis [19]. Moreover, Baker, Hughes and Savill [38]
demonstrate that cultured human and rat mesangial cells deprived
of growth factors can undergo apoptosis.
In our studies, typical apoptotic cells and apoptotic bodies were
recognized by both light and electron microscopy in the gbomer-
ulus. Further, nick end-labeled cells, which was confirmed as
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Fig. 6. TdT-mediated DNA nick end-labeled cells in glomendus at various time after disease induction. A. One week after disease induction. Numerous
nick end-labeled cells (J.) are found in marked proliferative regions. B. Two weeks after disease induction. Three nick end-labeled cells ( ) are found
in segmental proliferative regions. C. Three weeks after disease induction. Numerous nick end-labeled cells ()are still noted. Inset. A
polymorphonuclear leukocyte with positive stain by nick end-labeling method (1,). D. Six weeks after disease induction. No nick end-labeled cells are
found in the nearly recovered glomerulus. A—E; TdT-mediated DNA nick end-labeling method, X 600.
apoptotic by light microscopical observation of the neighboring
section, was also recognized in proliferative regions. Our morpho-
metrical studies showed that a few incidences of apoptosis oc-
curred in the early phase of Thy-1.1 GN, and the number of
apoptotic cells increased especially after glomerular proliferative
lesion occurred. The apoptosis continued at high incidence as
glomerular hypercellularity developed. Then, the number of ap-
optotic cells gradually decreased and only a few were present at
the time glomerular cellularity returned to their original state. We
therefore conclude that many apoptotic cells appearing during the
regression of glomerular hyperplasia are due to programmed
removal of excess "unwanted" glomerular cells.
Some experimental studies have demonstrated that the majority
of proliferating cells in Thy-1.1 GN originated from mesangial
cells [391, and glomerular hypercellularity is due to proliferative
smooth muscle-like mesangial cells [311. Our immunohistochem-
ical study found that the most of proliferating cells were also
expressing Thy-1.1 antigen, indicating the majority of proliferating
glomerular cells were of mesangial origin. Moreover, many Thy-
1.1 expression and nick end-labeled cells appeared in proliferative
regions during the recovery from GN. Our results strongly suggest
the possibility that apoptotic cells in proliferative regions origi-
nated from mesangial cells.
The infiltration of leukocytes, particularly neutrophils and
macrophages, into the glomerulus has been known for some time
in the human and experimental studies [40]. Recently, neutrophils
have been shown to undergo apoptosis in Thy- 1.1 GN, and
apoptotic neutrophils are ingested by mesangial cells and infil-
trated macrophages [22]. These processes have been considered
as limiting the neutrophil-mediated glomerular injury and may
play a role in determining whether there is resolution of glomer-
ular inflammation and the development of persistent inflamma-
tion leading to scarring. Our results also indicate that both
infiltrated neutrophils and macrophages undergo apoptosis. How-
ever, our morphometrical study shows that the number of apop-
totic cells did not significantly increase during rapid decrease of
infiltrated leukocytes in the early phase of Thy-1.1 GN. This
suggests that a small number of infiltrating neutrophils and
macrophages are eliminated by apoptosis.
On the other hand, Bagchus et al [41] report that apoptotic cells
are found during lytic injury process of mesangial cells soon after
Thy-1.1 antibody administration. In our study, the presence of
apoptotic cells was not conclusively confirmed in early phase of
Thy-1.1 GN, because our observation began at day 1, by which
time a majority of mesangial cells had lysed and disappeared from
the mesangial area. A work is in progress in our laboratory to
identify the induction of apoptotic cells in the process of immu-
nologically-mediated mesangial cell injury.
In conclusion, during the resolution of proliferative Thy-1.1
GN, proliferating glomerular cells are considered to be mainly
Shimizu et a!: Apoptosis in proliferative GN 121
proliferative mesangial cells which regress to their original cellu-
larity by apoptosis. The small number of infiltrated neutrophils
and macrophages are also eliminated by apoptosis. This study
strongly suggests that apoptosis is essential for the recoveiy to the
original structure in proliferative GN.
Reprint requests to Akira Shimizu, MD., Department of Pathology, Nippon
Medical School, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo, 113, Japan.
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